论文部分内容阅读
对于我国的处方药市场,国内外药企都一致看好。但我国药企起步晚,国内高端的医药市场,基本为外资药企所垄断,分析其原因主要是外资药企和国内药企在销售模式上有着本质的区别。作为国内药企的启蒙者,外资药企的学术推广体系早已形成了相当成熟且规范的操作模式。本文就国内药企模式转换结合“互联网+企业大学模式”浅略阐述其重要作用。
For the prescription drug market in China, pharmaceutical companies at home and abroad are unanimously optimistic. However, the late start of Chinese pharmaceutical companies, the domestic high-end pharmaceutical market, the basic monopoly of foreign pharmaceutical companies, analysis of the main reasons for the foreign pharmaceutical companies and domestic pharmaceutical companies in the sales model is essentially different. As the enlightenment of domestic pharmaceutical companies, the academic promotion system of foreign pharmaceutical enterprises has long formed a fairly mature and standardized operating mode. This article describes the important role of domestic pharmaceutical companies in the mode conversion combined with “Internet + Enterprise University Model.”